Skip to content
10-Q

Quarterly Report

Bionano Genomics, Inc. BNGO

0001411690-25-000083

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 7, 2025 4.68M sh
Shares Diluted Q2 2025 · Jun 30, 2025 3.44M sh
Shares Diluted Q2 2025 · Jun 30, 2025 3.07M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1.13M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$6.25M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$49.11M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $3.56M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $9.17M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $10.43M
Stockholders Equity Q2 2025 · Jun 30, 2025 $45.37M
Stockholders Equity Q2 2025 · Mar 31, 2025 $48.19M
Stockholders Equity Q2 2025 · Dec 31, 2024 $35.38M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 $80.34M
Stockholders Equity restated Q2 2025 · Mar 31, 2024 $82.77M
Stockholders Equity Q2 2025 · Dec 31, 2023 $96.16M
Current Liabilities Q2 2025 · Jun 30, 2025 $24.18M
Current Liabilities Q2 2025 · Dec 31, 2024 $37.34M
Total Liabilities Q2 2025 · Jun 30, 2025 $30.64M
Total Liabilities Q2 2025 · Dec 31, 2024 $41.3M
Current Assets Q2 2025 · Jun 30, 2025 $42.66M
Current Assets Q2 2025 · Dec 31, 2024 $39.49M
Total Assets Q2 2025 · Jun 30, 2025 $76.01M
Total Assets Q2 2025 · Dec 31, 2024 $76.67M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.99
Eps Diluted Q2 2025 · Jun 30, 2025 −$3.24
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$14.41
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$47.50
Eps Basic Q2 2025 · Jun 30, 2025 −$1.99
Eps Basic Q2 2025 · Jun 30, 2025 −$3.24
Eps Basic restated Q2 2025 · Jun 30, 2024 −$14.41
Eps Basic restated Q2 2025 · Jun 30, 2024 −$47.50
Sga Expense Q2 2025 · Jun 30, 2025 $8.35M
Sga Expense Q2 2025 · Jun 30, 2025 $17.38M
Sga Expense Q2 2025 · Jun 30, 2024 $11.56M
Sga Expense restated Q2 2025 · Jun 30, 2024 $30.64M
Rd Expense Q2 2025 · Jun 30, 2025 $2.93M
Rd Expense Q2 2025 · Jun 30, 2025 $5.3M
Rd Expense Q2 2025 · Jun 30, 2024 $6.83M
Rd Expense Q2 2025 · Jun 30, 2024 $16.61M
Net Income Q2 2025 · Jun 30, 2025 −$6.86M
Net Income Q2 2025 · Jun 30, 2025 −$9.96M
Net Income Q2 2025 · Mar 31, 2025 −$3.1M
Net Income Q2 2025 · Jun 30, 2024 −$16.22M
Net Income Q2 2025 · Jun 30, 2024 −$47.65M
Net Income Q2 2025 · Mar 31, 2024 −$31.42M
Operating Income Q2 2025 · Jun 30, 2025 −$7.8M
Operating Income Q2 2025 · Jun 30, 2025 −$16.26M
Operating Income Q2 2025 · Jun 30, 2024 −$17.02M
Operating Income Q2 2025 · Jun 30, 2024 −$48.14M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $3.26M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $6.77M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $5.19M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $11.13M
Revenue Q2 2025 · Jun 30, 2025 $6.73M
Revenue Q2 2025 · Jun 30, 2025 $13.19M
Revenue Q2 2025 · Jun 30, 2024 $7.77M
Revenue Q2 2025 · Jun 30, 2024 $16.54M